Edition:
United States

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.84USD
20 Aug 2018
Change (% chg)

$0.07 (+1.86%)
Prev Close
$3.77
Open
$3.78
Day's High
$3.84
Day's Low
$3.77
Volume
4,582
Avg. Vol
23,929
52-wk High
$5.34
52-wk Low
$2.88

Chart for

About

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $77.92
Shares Outstanding(Mil.): 20.67
Dividend: --
Yield (%): --

Financials

  BCLI.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -0.39 -- --
ROI: -74.55 2.89 12.63
ROE: -74.55 1.65 14.82

BRIEF-BrainStorm Cell Therapuetics Reports Q1 Loss Per Share Of $0.12

* BRAINSTORM ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE AND CLINICAL HIGHLIGHTS

May 14 2018

Earnings vs. Estimates